phenytoin has been researched along with haloperidol in 76 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 34 (44.74) | 18.7374 |
| 1990's | 10 (13.16) | 18.2507 |
| 2000's | 15 (19.74) | 29.6817 |
| 2010's | 15 (19.74) | 24.3611 |
| 2020's | 2 (2.63) | 2.80 |
| Authors | Studies |
|---|---|
| Creveling, CR; Daly, JW; Lewandowski, GA; McNeal, ET | 1 |
| Andrews, PR; Craik, DJ; Martin, JL | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Du, LP; Li, MY; Tsai, KC; Xia, L; You, QD | 1 |
| Caron, G; Ermondi, G | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Abraham, MH; Acree, WE; Ibrahim, A | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Boriss, H; Braggio, S; Corbioli, S; Fontana, S; Helmdach, L; Longhi, R; Schiller, J; Vinco, F | 1 |
| Sen, S; Sinha, N | 1 |
| Cooper, J; Cui, Y; Fink, M; Gavaghan, DJ; Heath, BM; McMahon, NC; Mirams, GR; Noble, D; Sher, A | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Brown, AM; Bruening-Wright, A; Kramer, J; Kuryshev, YA; Myatt, G; Obejero-Paz, CA; Verducci, JS | 1 |
| Brouillette, WJ; Brown, GB; Zha, C | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Bloomer, WD; Papadopoulou, MV; Rosenzweig, HS | 1 |
| Chłoń-Rzepa, G; Dąbrowska, M; Jankowska, A; Komsta, Ł; Pawłowski, M; Ślusarczyk, M; Starek, M; Zagórska, A | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Fukuyama, Y; Hayakawa, T; Miyagawa, F; Ochiai, Y | 1 |
| Olbrich, R | 1 |
| Klawans, HL; Koller, WC; Nausieda, PA; Weiner, WJ | 1 |
| Lechin, F; van der Dijs, B | 1 |
| Bellak, L | 1 |
| Zetler, G | 1 |
| Heggeness, L; McCullar, FW | 1 |
| Goldman, SA | 1 |
| Codd, EE; Shank, RP | 1 |
| Enna, SJ; Karbon, EW | 1 |
| Karbon, EW; Naper, K; Pontecorvo, MJ | 1 |
| Kondo, T; Ohta, Y; Tamaya, S; Yamabayashi, H | 1 |
| Cennamo, M; Piccione, E; Ticconi, C | 1 |
| Akaike, N; Kaneda, M; Oyama, Y; Wakamori, M | 1 |
| Getova, D; Markovska, V | 1 |
| Defazio, G; Di Reda, N; Giovine, A; Lanzi, C; Lepore, V; Livrea, P; Pedone, D; Tartaglione, B | 1 |
| Mitsuma, T; Nogimori, T | 1 |
| Perry, DC | 1 |
| Dittmar, G; Lincke, HO | 1 |
| Greendyke, RM; Gulya, A | 1 |
| Davidson, S; Falconer, MA | 1 |
| Gogerty, JH; Iorio, LC; Ryan, EA | 1 |
| Clark, DB; Critchley, EM; Wikler, A | 1 |
| Brittain, RT | 1 |
| Bruun, A; Ehinger, B | 1 |
| Barnett, MP; Blask, DE; Reiter, RJ; Talbot, JA | 1 |
| Gudauskas, GA; Lien, EJ | 1 |
| Flessa, HC; Sigell, LT | 1 |
| Collins, AJ; Horlington, M | 1 |
| Horiuchi, M; Ibii, N; Yamamoto, K | 1 |
| Monninger, P; Przuntek, H | 1 |
| Czuczwar, SJ; Kleinrok, Z; Kozicka, M | 1 |
| Müller-Oerlinghausen, B; Schley, J | 1 |
| Auvinen, J; Linnoila, M; Vaisanen, K; Viukari, M | 1 |
| Ikeda, H | 1 |
| Kleinberg, ML; Latiolais, CJ; Stauffer, GL | 1 |
| Ganapathy, V; Leibach, FH; Mahesh, VB; Ramamoorthy, JD; Ramamoorthy, S | 1 |
| Bailey, MA; Karbon, EW | 1 |
| Crisci, M; de Carolis, P; Laudadio, S; Pezzoli, A; Sacquegna, T | 1 |
| Mol, CA; Schinkel, AH; van Deemter, L; Wagenaar, E | 1 |
| Fei, YJ; Ganapathy, V; Huang, W; Leibach, FH; Li, HW; Seth, P | 1 |
| Crismon, ML; Dorson, PG; Lee, JW | 1 |
| Belmaker, RH; Bersudsky, Y; Mishory, A; Yaroslavsky, Y | 1 |
| Hamann, M; Meisler, MH; Richter, A | 1 |
| Baeyens, JM; Cobos, EJ; Del Pozo, E | 1 |
| Awata, S; Ebina, Y; Honda, T; Matsuoka, H; Miura, N; Shindo, T; Suzuki, K; Takano, T | 1 |
| Chu, K; Jung, KH; Lee, SK; Nam, H; Park, KI; Sinn, DI | 1 |
| Glezer, A; Yuan, N | 1 |
| Digby, G; Jalini, S; Taylor, S | 1 |
| Rosini, JM; Whyte, CJ | 1 |
5 review(s) available for phenytoin and haloperidol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Organic delusional disorder on a consultation-liaison psychiatry service. Report and review.
Topics: Adult; Age Factors; Aged; Brain Diseases; Delusions; Diagnosis, Differential; Electroencephalography; Haloperidol; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Phenytoin; Psychiatric Department, Hospital; Psychiatric Status Rating Scales; Referral and Consultation; Tomography, X-Ray Computed | 1992 |
Pharmacological characterization of sigma binding sites in guinea pig brain membranes.
Topics: Animals; Brain; Dextromethorphan; Drug Synergism; Guinea Pigs; Haloperidol; Membranes; Phenytoin; Receptors, N-Methyl-D-Aspartate; Receptors, Opioid; Receptors, sigma | 1991 |
[Problems of neurological drug therapy in pregnancy].
Topics: Abnormalities, Drug-Induced; Anticonvulsants; Antiparkinson Agents; Carbamazepine; Chelating Agents; Female; Fetus; Haloperidol; Humans; Nervous System Diseases; Phenobarbital; Phenytoin; Pregnancy; Pregnancy Complications; Trimethadione; Valproic Acid | 1989 |
[Therapy in alcoholic delirium].
Topics: Alcohol Withdrawal Delirium; Carbamazepine; Chlormethiazole; Diazepam; Haloperidol; Humans; Phenytoin; Psychoses, Alcoholic | 1987 |
1 trial(s) available for phenytoin and haloperidol
| Article | Year |
|---|---|
Phenytoin as an antimanic anticonvulsant: a controlled study.
Topics: Anticonvulsants; Antimanic Agents; Bipolar Disorder; Brief Psychiatric Rating Scale; Double-Blind Method; Drug Administration Schedule; Female; Haloperidol; Humans; Male; Phenytoin; Placebos; Psychiatric Status Rating Scales; Psychotic Disorders; Sodium Channels; Treatment Outcome | 2000 |
70 other study(ies) available for phenytoin and haloperidol
| Article | Year |
|---|---|
[3H]Batrachotoxinin A 20 alpha-benzoate binding to voltage-sensitive sodium channels: a rapid and quantitative assay for local anesthetic activity in a variety of drugs.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Batrachotoxins; Calcium Channel Blockers; Cyclic AMP; Guinea Pigs; Histamine H1 Antagonists; In Vitro Techniques; Ion Channels; Neurotoxins; Sodium; Tranquilizing Agents; Tritium | 1985 |
Functional group contributions to drug-receptor interactions.
Topics: Animals; Calorimetry; Kinetics; Models, Biological; Protein Binding; Receptors, Cell Surface; Receptors, Drug; Structure-Activity Relationship | 1984 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
The pharmacophore hypotheses of I(Kr) potassium channel blockers: novel class III antiarrhythmic agents.
Topics: Anti-Arrhythmia Agents; Models, Biological; Models, Molecular; Potassium Channel Blockers; Potassium Channels; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2004 |
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).
Topics: 1-Octanol; Alkanes; Hydrogen-Ion Concentration; Least-Squares Analysis; Mathematics; Models, Chemical; Models, Molecular; Solvents; Water | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.
Topics: Air; Animals; Humans; Lung; Organic Chemicals; Probability; Rats; Tissue Distribution; Volatilization | 2008 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Brain tissue binding of drugs: evaluation and validation of solid supported porcine brain membrane vesicles (TRANSIL) as a novel high-throughput method.
Topics: Absorption; Albumins; Animals; Brain; Brain Chemistry; Cell Membrane; Chromatography, High Pressure Liquid; Drug Evaluation, Preclinical; In Vitro Techniques; Lipids; Male; Microdialysis; Pharmaceutical Preparations; Protein Binding; Rats; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Swine; Tissue Distribution | 2011 |
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.
Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship | 2011 |
Simulation of multiple ion channel block provides improved early prediction of compounds' clinical torsadogenic risk.
Topics: Action Potentials; Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Computer Simulation; Dogs; Dose-Response Relationship, Drug; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Guinea Pigs; HEK293 Cells; Humans; Ion Channels; Kinetics; Models, Cardiovascular; NAV1.5 Voltage-Gated Sodium Channel; Patch-Clamp Techniques; Potassium Channel Blockers; Rabbits; Risk Assessment; Risk Factors; Sodium Channel Blockers; Sodium Channels; Torsades de Pointes; Transfection | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
MICE models: superior to the HERG model in predicting Torsade de Pointes.
Topics: ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Models, Theoretical; Patch-Clamp Techniques; Predictive Value of Tests; Torsades de Pointes | 2013 |
A highly predictive 3D-QSAR model for binding to the voltage-gated sodium channel: design of potent new ligands.
Topics: Ligands; Models, Molecular; Quantitative Structure-Activity Relationship; Voltage-Gated Sodium Channels | 2014 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
The antitubercular activity of various nitro(triazole/imidazole)-based compounds.
Topics: Animals; Antitubercular Agents; Cell Line; Chlorocebus aethiops; Dose-Response Relationship, Drug; Humans; Imidazoles; Macrophages; Mice; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nitro Compounds; Structure-Activity Relationship; Triazoles | 2017 |
Estimation of the lipophilicity of purine-2,6-dione-based TRPA1 antagonists and PDE4/7 inhibitors with analgesic activity.
Topics: Analgesics; Benzeneacetamides; Cyclic Nucleotide Phosphodiesterases, Type 7; Hydrophobic and Hydrophilic Interactions; Molecular Structure; Phenylbutyrates; Phosphodiesterase 4 Inhibitors; Principal Component Analysis; Quantitative Structure-Activity Relationship; TRPA1 Cation Channel; Xanthines | 2021 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Overnight sleep EEG and cerebrospinal fluid monoamines in seizures induced by movement.
Topics: Child; Electroencephalography; Haloperidol; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levodopa; Male; Movement; Pedigree; Phenylacetates; Phenytoin; Seizures; Sleep; Sleep, REM | 1979 |
Alcohol withdrawal states and the need for treatment.
Topics: Adult; Alcoholism; Chlormethiazole; Drug Therapy, Combination; Emergencies; Female; Haloperidol; Humans; Personality Inventory; Phenytoin; Psychoses, Alcoholic; Seizures; Substance Withdrawal Syndrome | 1979 |
Clinical and experimental studies of phenytoin-induced hyperkinesias.
Topics: Aged; Animals; Apomorphine; Basal Ganglia; Corpus Striatum; Dextroamphetamine; Disease Models, Animal; Drug Synergism; Dyskinesia, Drug-Induced; Female; Guinea Pigs; Haloperidol; Humans; Hyperkinesis; Male; Middle Aged; Phenytoin; Stereotyped Behavior | 1979 |
Effects of diphenylhydantoin (DPH) on distal colon motility.
Topics: Adult; Colon; Colon, Sigmoid; Female; Gastrointestinal Motility; Haloperidol; Humans; Male; Manometry; Phenytoin; Rectum; Sulpiride | 1979 |
A possible subgroup of the schizophrenic syndrome and implications for treatment.
Topics: Adolescent; Adult; Attention Deficit Disorder with Hyperactivity; Diazepam; Dominance, Cerebral; Dyslexia; Female; Haloperidol; Humans; Imipramine; Impulsive Behavior; Learning Disabilities; Male; Methylphenidate; Middle Aged; Phenytoin; Psychoanalytic Therapy; Schizophrenia; Self Concept; Space Perception | 1976 |
Haloperidol catalepsy in grouped and isolated mice.
Topics: Animals; Behavior, Animal; Catalepsy; Drug Interactions; Haloperidol; Humans; Injections, Subcutaneous; Male; Mice; Nikethamide; Phenytoin; Social Isolation | 1975 |
Limb malformations following maternal use of haloperidol.
Topics: Abnormalities, Drug-Induced; Abnormalities, Multiple; Drug Therapy, Combination; Female; Fetus; Haloperidol; Humans; Infant, Newborn; Infant, Premature; Limb Deformities, Congenital; Male; Maternal-Fetal Exchange; Methylphenidate; Phenytoin; Pregnancy; Pregnancy Trimester, First; Psychotic Disorders | 1975 |
1,3-Di(2-[5-3H]tolyl)guanidine labels more than one site in rat forebrain.
Topics: Animals; Binding Sites; Binding, Competitive; Carbamazepine; Guanidines; Haloperidol; Male; Pentazocine; Phenytoin; Piperidines; Prosencephalon; Rats; Rats, Wistar; Receptors, sigma; Stereoisomerism | 1992 |
[3H]DTG and [3H](+)-3-PPP label pharmacologically distinct sigma binding sites in guinea pig brain membranes.
Topics: Animals; Binding, Competitive; Brain; Dextromethorphan; Dopamine Agents; Guanidines; Guinea Pigs; Haloperidol; In Vitro Techniques; Kinetics; Membranes; Phenazocine; Phenytoin; Piperidines; Receptors, Opioid; Receptors, sigma | 1991 |
Dual-respiratory rhythms. A key to diagnosis of diaphragmatic flutter in patients with HVS.
Topics: Adolescent; Adult; Carbon Dioxide; Diaphragm; Electromyography; Female; Haloperidol; Humans; Hyperventilation; Male; Phenytoin; Respiration; Syndrome | 1989 |
Effects of chlordiazepoxide, chlorpromazine, diazepam, diphenylhydantoin, flunitrazepam and haloperidol on the voltage-dependent sodium current of isolated mammalian brain neurons.
Topics: Animals; Chlordiazepoxide; Chlorpromazine; Diazepam; Flunitrazepam; Haloperidol; Hippocampus; In Vitro Techniques; Membrane Potentials; Phenytoin; Psychotropic Drugs; Rats; Sodium | 1989 |
Study of the participation of the dopaminergic transmission system in the effects of two newly synthesized barbiturates.
Topics: Animals; Apomorphine; Barbiturates; Catalepsy; Haloperidol; Male; Pentobarbital; Phenytoin; Rats; Receptors, Dopamine; Stereotyped Behavior; Synaptic Transmission | 1988 |
Dopaminomimetic action of diphenylhydantoin in rat striatum: effect on homovanillic acid and cyclic AMP levels.
Topics: Animals; Apomorphine; Corpus Striatum; Cyclic AMP; Dyskinesia, Drug-Induced; Haloperidol; Homovanillic Acid; Humans; Male; Phenylacetates; Phenytoin; Psychoses, Substance-Induced; Rats; Rats, Inbred Strains; Receptors, Dopamine | 1985 |
Effects of various drugs on thyrotropin secretion in rats.
Topics: 5-Hydroxytryptophan; Animals; Dose-Response Relationship, Drug; Endorphins; Fenclonine; Haloperidol; Hypothalamus; Levodopa; Male; Melatonin; Phenytoin; Protein Precursors; Rats; Rats, Inbred Strains; Thyrotropin; Thyrotropin-Releasing Hormone; Time Factors | 1985 |
Barrel rotation in rats induced by intracerebroventricular bradykinin antagonists.
Topics: Animals; Atropine; Bradykinin; Captopril; Diazepam; Dose-Response Relationship, Drug; Haloperidol; Injections, Intraventricular; Male; Motor Activity; Muscimol; Naloxone; Phenobarbital; Phenytoin; Posture; Rats; Rats, Inbred Strains; Structure-Activity Relationship | 1987 |
Effect of pindolol administration on serum levels of thioridazine, haloperidol, phenytoin, and phenobarbital.
Topics: Adult; Aged; Drug Interactions; Drug Therapy, Combination; Haloperidol; Humans; Male; Middle Aged; Neurocognitive Disorders; Phenobarbital; Phenytoin; Pindolol; Rage; Thioridazine; Violence | 1988 |
Coarse features in epilepsy as a consequence of anticonvulsant therapy. Report of cases in two pairs of identical twins.
Topics: Acromegaly; Adult; Anticonvulsants; Carbamazepine; Child; Diazepam; Diseases in Twins; Epilepsy; Epilepsy, Tonic-Clonic; Ethosuximide; Face; Female; Haloperidol; Humans; Hydantoins; Male; Phenobarbital; Phenytoin; Primidone; Thiazines | 1973 |
Anticonvulsant testing with a new analeptic convulsant: N-sulfamoyl-hexahydro-azepine (Sah 41-178).
Topics: Acetamides; Animals; Anticonvulsants; Azepines; Central Nervous System Stimulants; Chlordiazepoxide; Chlorpromazine; Diazepam; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Electroshock; Glutethimide; Haloperidol; Male; Mice; Pentylenetetrazole; Phenobarbital; Phenytoin; Strychnine; Sulfonamides; Trimethadione | 1973 |
An adult form of acanthocytosis.
Topics: Abetalipoproteinemia; Adult; Ataxia; Diazepam; Female; Haloperidol; Humans; Huntington Disease; Hydroxyzine; Male; Phenobarbital; Phenytoin; Trihexyphenidyl | 1967 |
The intracerebral effects of noradrenaline and its modification by drugs in the mouse.
Topics: Amitriptyline; Animals; Antidepressive Agents; Ataxia; Atropine; Body Temperature; Brain; Central Nervous System; Chlordiazepoxide; Chlorpheniramine; Chlorpromazine; Diazepam; Drug Antagonism; Haloperidol; Histamine H1 Antagonists; Imipramine; Male; Mice; Norepinephrine; Nortriptyline; Pentobarbital; Phenytoin; Piperazines; Trihexyphenidyl | 1966 |
Uptake of the putative neurotransmitter, glycine, into the rabbit retina.
Topics: Alanine; Aminobutyrates; Animals; Aspartic Acid; Desipramine; Diazepam; Dinitrophenols; Glutamates; Glutethimide; Glycine; Haloperidol; Lysine; Meprobamate; Neurons; Neurotransmitter Agents; Ouabain; Phenytoin; Rabbits; Retina; Synaptic Transmission; Temperature | 1972 |
Nature and the time course of seizures associated with surgical removal of the pineal gland from parathyroidectomized rats.
Topics: Animals; Chlordiazepoxide; Chlorpromazine; Diazepam; Haloperidol; Male; Parathyroid Glands; Phenytoin; Pineal Gland; Rats; Seizures; Time Factors | 1973 |
Structure side-effect sorting of drugs. I. Extrapyramidal syndrome.
Topics: Anticonvulsants; Basal Ganglia Diseases; Benzamides; Computers; Diazepam; Drug-Related Side Effects and Adverse Reactions; Haloperidol; Humans; Movement Disorders; Phenothiazines; Phenytoin; Structure-Activity Relationship; Tranquilizing Agents | 1973 |
Drug interactions with anticoagulants.
Topics: Acetaminophen; Animals; Anti-Bacterial Agents; Anticoagulants; Ascorbic Acid; Barbiturates; Blood Coagulation; Blood Coagulation Tests; Cardiac Glycosides; Chlordiazepoxide; Chlorothiazide; Contraceptives, Oral; Diazepam; Dogs; Drug Antagonism; Epinephrine; Ethchlorvynol; Glucagon; Haloperidol; Humans; Methylphenidate; Phenethylamines; Phenylbutazone; Phenytoin; Quinolines; Salicylates; Steroids; Substance-Related Disorders; Tetanus Toxoid; Tolbutamide; Xanthines | 1970 |
A sequential screning test based on the running component of audiogenic seizures in mice, including reference compound PD50 values.
Topics: Acetazolamide; Animals; Anticonvulsants; Atropine; Chloral Hydrate; Chlordiazepoxide; Ethosuximide; Haloperidol; Hydroxybutyrates; Hypnotics and Sedatives; Meprobamate; Methods; Mice; Motor Activity; Orphenadrine; Phenobarbital; Phenytoin; Primidone; Sound | 1969 |
[Pharmacology of a 1H-1, 2, 4-triazolyl benzophenone derivative (450191-S), a new sleep-inducer (III). Behavioral study on interactions of 450191-S and other drugs in mice].
Topics: Aminopyrine; Animals; Anti-Anxiety Agents; Apomorphine; Behavior, Animal; Benzodiazepines; Central Nervous System; Central Nervous System Agents; Haloperidol; Hypnotics and Sedatives; Imipramine; Male; Mice; Pentylenetetrazole; Phenytoin; Reserpine; Triazoles | 1984 |
Therapeutic aspects of kinesiogenic paroxysmal choreoathetosis and familial paroxysmal choreoathetosis of the Mount and Reback type.
Topics: Adolescent; Adult; Aged; Alcohol Drinking; Athetosis; Carbamazepine; Child; Chorea; Female; Haloperidol; Humans; Male; Middle Aged; Motor Activity; Pedigree; Phenytoin; Primidone; Valproic Acid | 1983 |
Effect of dopaminergic and GABA-ergic drugs given alone or in combination on the anticonvulsant action of phenobarbital and diphenylhydantoin in the electroshock test in mice.
Topics: Amantadine; Aminooxyacetic Acid; Amphetamine; Animals; Apomorphine; Baclofen; Dopamine; Electroshock; Female; Fluphenazine; gamma-Aminobutyric Acid; Haloperidol; Hydroxybutyrates; Levodopa; Male; Mice; Phenobarbital; Phenytoin; Receptors, Neurotransmitter; Seizures | 1980 |
The binding of chemically different psychotropic drugs to alpha 1-acid glycoprotein.
Topics: Diazepam; Haloperidol; Humans; Imipramine; Kinetics; Orosomucoid; Perazine; Phenobarbital; Phenytoin; Protein Binding; Psychotropic Drugs; Structure-Activity Relationship | 1983 |
Effect of anticonvulsants on plasma haloperidol and thioridazine levels.
Topics: Adult; Drug Therapy, Combination; Epilepsy, Tonic-Clonic; Female; Haloperidol; Humans; Intellectual Disability; Male; Mesoridazine; Phenobarbital; Phenytoin; Thioridazine | 1980 |
[Pharmacological studies on the functional development of the central nervous system in first generation rats born to phenytoin-treated mothers (author's transl)].
Topics: Animals; Animals, Newborn; Ataxia; Birth Rate; Brain; Catalepsy; Diazepam; Eye; Feeding Behavior; Female; Haloperidol; Humans; Male; Pentobarbital; Phenytoin; Pregnancy; Pregnancy, Animal; Prenatal Exposure Delayed Effects; Rats; Rats, Inbred Strains; Sleep | 1982 |
Stability of five liquid drug products after unit dose repackaging.
Topics: Drug Packaging; Drug Stability; Haloperidol; Isoetharine; Kinetics; Medication Systems, Hospital; Pentazocine; Phenytoin; Promethazine; Temperature | 1980 |
Cocaine-sensitive sigma-receptor and its interaction with steroid hormones in the human placental syncytiotrophoblast and in choriocarcinoma cells.
Topics: Choriocarcinoma; Cocaine; Female; Giant Cells; Gonadal Steroid Hormones; Haloperidol; Humans; Ligands; Neuropeptide Y; Phenytoin; Placenta; Pregnancy; Receptors, sigma; Trophoblasts; Tumor Cells, Cultured; Uterine Neoplasms | 1995 |
Haloperidol treatment differentially regulates [3H]DTG and [3H](+)-3-PPP labeled sigma binding sites.
Topics: Animals; Antipsychotic Agents; Binding Sites; Brain; Dopamine Agents; Drug Administration Schedule; Guanidines; Guinea Pigs; Haloperidol; Male; Phenytoin; Piperidines; Receptors, sigma | 1993 |
Acute psychosis and epileptic seizures as the presenting symptom of late-onset epilepsy.
Topics: Aged; Cerebral Cortex; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electroencephalography; Epilepsy; Epilepsy, Complex Partial; Epilepsy, Tonic-Clonic; Female; Haloperidol; Humans; Male; Neurocognitive Disorders; Phenytoin | 1994 |
P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Blood-Brain Barrier; Brain; Cell Line; Clozapine; Diffusion; Domperidone; Epithelium; Flunitrazepam; Haloperidol; Humans; Kidney; Kinetics; Loperamide; Male; Mice; Mice, Inbred Strains; Ondansetron; Phenytoin; Recombinant Proteins; Structure-Activity Relationship; Swine; Tissue Distribution; Transfection | 1996 |
Cloning and functional characterization of a sigma receptor from rat brain.
Topics: Amino Acid Sequence; Animals; Anticonvulsants; Antidepressive Agents; Base Sequence; Binding, Competitive; Brain Chemistry; Choriocarcinoma; Cloning, Molecular; Clorgyline; DNA, Complementary; Dopamine Antagonists; Gene Expression; Gene Library; Guanidines; Haloperidol; HeLa Cells; Humans; Kinetics; Liver; Molecular Sequence Data; Narcotics; Pentazocine; Phenytoin; Placenta; Rats; Receptors, sigma; RNA, Messenger; Steroids | 1998 |
Seizure associated with olanzapine.
Topics: Adult; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Drug Interactions; Female; Haloperidol; Humans; Olanzapine; Phenytoin; Pirenzepine; Seizures | 1999 |
Motor disturbances in mice with deficiency of the sodium channel gene Scn8a show features of human dystonia.
Topics: Animals; Anti-Dyskinesia Agents; Anticonvulsants; Biperiden; Brain; Diazepam; Disease Models, Animal; Dystonia; Electroencephalography; Haloperidol; Humans; Immunohistochemistry; Mice; Mice, Mutant Strains; Motor Activity; Muscarinic Antagonists; Muscle, Skeletal; NAV1.6 Voltage-Gated Sodium Channel; Nerve Tissue Proteins; Phenytoin; Sodium Channels; Tyrosine 3-Monooxygenase | 2003 |
Phenytoin differentially modulates the affinity of agonist and antagonist ligands for sigma 1 receptors of guinea pig brain.
Topics: Allosteric Regulation; Animals; Anisoles; Anticonvulsants; Binding, Competitive; Brain; Dextromethorphan; Drug Interactions; Ethylenediamines; Guinea Pigs; Haloperidol; Ligands; Male; Morpholines; Neurons; Phenazocine; Phenytoin; Piperazines; Piperidines; Progesterone; Propylamines; Receptors, sigma; Synaptic Transmission | 2005 |
Epileptic seizures superimposed on catatonic stupor.
Topics: Aged; Anticonvulsants; Antipsychotic Agents; Bipolar Disorder; Catatonia; Combined Modality Therapy; Comorbidity; Electroconvulsive Therapy; Electroencephalography; Epilepsy; Female; Haloperidol; Humans; Male; Middle Aged; Phenytoin; Schizophrenia, Catatonic; Treatment Outcome | 2006 |
Status epilepticus associated with sertindole.
Topics: Anticonvulsants; Antipsychotic Agents; Brain; Brain Chemistry; Dose-Response Relationship, Drug; Electroencephalography; Female; Haloperidol; Humans; Imidazoles; Indoles; Middle Aged; Phenytoin; Receptor, Serotonin, 5-HT2C; Schizophrenia; Serotonin; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Status Epilepticus; Treatment Outcome | 2007 |
A young woman presenting with psychotic and mood symptoms from anti-N-methyl-D-aspartate receptor (NMDA-R) encephalitis: an emerging diagnosis.
Topics: Adult; Affective Disorders, Psychotic; Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Antibodies, Monoclonal, Murine-Derived; Anticonvulsants; Antipsychotic Agents; Diagnosis, Differential; Dibenzothiazepines; Electroencephalography; Female; Follow-Up Studies; Haloperidol; Humans; Immunologic Factors; Lorazepam; Phenytoin; Plasmapheresis; Quetiapine Fumarate; Rituximab; Treatment Outcome; Young Adult | 2013 |
Medication-induced acute dystonic reaction: the challenge of diagnosing movement disorders in the intensive care unit.
Topics: Antipsychotic Agents; Benzodiazepines; Brain; Diphenhydramine; Dyskinesia, Drug-Induced; Haloperidol; Humans; Intensive Care Units; Male; Middle Aged; Phenytoin; Status Epilepticus; Stroke; Tomography, X-Ray Computed | 2015 |
Dantrolene for Treatment of Suspected Neuroleptic Malignant Syndrome.
Topics: Analgesics, Opioid; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Dantrolene; Diagnosis, Differential; Fentanyl; Haloperidol; Humans; Levetiracetam; Male; Middle Aged; Neuroleptic Malignant Syndrome; Olanzapine; Phenytoin; Piracetam | 2018 |